Ami Navon - Publications

Affiliations: 
Weizmann Institute of Science, Rehovot, Israel 
Area:
Cell Biology, Molecular Biology, Biochemistry

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tabachnick-Cherny S, Pinto S, Berko D, Curato C, Wolf Y, Porat Z, Karmona R, Tirosh B, Jung S, Navon A. Polyglutamine-Related Aggregates Can Serve as a Potent Antigen Source for Cross-Presentation by Dendritic Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 33067378 DOI: 10.4049/jimmunol.1901535  0.48
2019 Weinberger L, Stanhill A, Boim A, Meyer K, Leitner O, Hamawi H, Navon A. Abstract 3243: A CTLA4 antibody with enhanced properties Cancer Research. 79: 3243-3243. DOI: 10.1158/1538-7445.Am2019-3243  0.44
2017 Demishtein A, Fraiberg M, Berko D, Tirosh B, Elazar Z, Navon A. SQSTM1/p62-mediated autophagy compensates for loss of proteasome polyubiquitin recruiting capacity. Autophagy. 0. PMID 28792301 DOI: 10.1080/15548627.2017.1356549  0.48
2015 Altun M, Walter TS, Kramer HB, Herr P, Iphöfer A, Boström J, David Y, Komsany A, Ternette N, Navon A, Stuart DI, Ren J, Kessler BM. The human otubain2-ubiquitin structure provides insights into the cleavage specificity of poly-ubiquitin-linkages. Plos One. 10: e0115344. PMID 25590432 DOI: 10.1371/Journal.Pone.0115344  0.84
2015 Altun M, Walter TS, Kramer HB, Herr P, Iphöfer A, Boström J, David Y, Komsany A, Ternette N, Navon A, Stuart DI, Ren J, Kessler BM. OTUB2 has a broader cleavage profile than OTUB1. Plos One. DOI: 10.1371/Journal.Pone.0115344.G005  0.48
2014 Piterman R, Braunstein I, Isakov E, Ziv T, Navon A, Cohen S, Stanhill A. VWA domain of S5a restricts the ability to bind ubiquitin and Ubl to the 26S proteasome. Molecular Biology of the Cell. 25: 3988-98. PMID 25318673 DOI: 10.1091/Mbc.E13-11-0697  0.84
2014 Raule M, Cerruti F, Benaroudj N, Migotti R, Kikuchi J, Bachi A, Navon A, Dittmar G, Cascio P. PA28αβ reduces size and increases hydrophilicity of 20S immunoproteasome peptide products. Chemistry & Biology. 21: 470-80. PMID 24631123 DOI: 10.1016/J.Chembiol.2014.02.006  0.84
2014 Tsvetkov P, Myers N, Eliav R, Adamovich Y, Hagai T, Adler J, Navon A, Shaul Y. NADH Binds and stabilizes the 26S proteasomes independent of ATP Journal of Biological Chemistry. 289: 11272-11281. PMID 24596095 DOI: 10.1074/Jbc.M113.537175  0.84
2014 Berko D, Herkon O, Braunstein I, Isakov E, David Y, Ziv T, Navon A, Stanhill A. Inherent asymmetry in the 26S proteasome is defined by the ubiquitin receptor RPN13. The Journal of Biological Chemistry. 289: 5609-18. PMID 24429290 DOI: 10.1074/Jbc.M113.509380  0.84
2012 Berko D, Tabachnick-Cherny S, Shental-Bechor D, Cascio P, Mioletti S, Levy Y, Admon A, Ziv T, Tirosh B, Goldberg AL, Navon A. The direction of protein entry into the proteasome determines the variety of products and depends on the force needed to unfold its two termini. Molecular Cell. 48: 601-11. PMID 23041283 DOI: 10.1016/J.Molcel.2012.08.029  0.84
2012 Pomerantz Y, Elbaz J, Ben-Eliezer I, Reizel Y, David Y, Galiani D, Nevo N, Navon A, Dekel N. From ubiquitin-proteasomal degradation to CDK1 inactivation: requirements for the first polar body extrusion in mouse oocytes. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4495-505. PMID 22859367 DOI: 10.1096/Fj.12-209866  0.84
2011 David Y, Ternette N, Edelmann MJ, Ziv T, Gayer B, Sertchook R, Dadon Y, Kessler BM, Navon A. E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes. The Journal of Biological Chemistry. 286: 44104-15. PMID 21965653 DOI: 10.1074/Jbc.M111.234559  0.84
2011 Shimshon L, Michaeli A, Hadar R, Nutt SL, David Y, Navon A, Waisman A, Tirosh B. SUMOylation of Blimp-1 promotes its proteasomal degradation. Febs Letters. 585: 2405-9. PMID 21722636 DOI: 10.1016/J.Febslet.2011.06.022  0.84
2011 Kario E, Amar N, Elazar Z, Navon A. A new autophagy-related checkpoint in the degradation of an ERAD-M target. The Journal of Biological Chemistry. 286: 11479-91. PMID 21228276 DOI: 10.1074/Jbc.M110.177618  0.84
2010 Li X, Wood TE, Sprangers R, Jansen G, Franke NE, Mao X, Wang X, Zhang Y, Verbrugge SE, Adomat H, Li ZH, Trudel S, Chen C, Religa TL, Jamal N, ... ... Navon A, et al. Effect of noncompetitive proteasome inhibition on bortezomib resistance. Journal of the National Cancer Institute. 102: 1069-82. PMID 20505154 DOI: 10.1093/Jnci/Djq198  0.84
2010 David Y, Ziv T, Admon A, Navon A. The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. The Journal of Biological Chemistry. 285: 8595-604. PMID 20061386 DOI: 10.1074/Jbc.M109.089003  0.84
2010 Navon A, Gatushkin A, Zelcbuch L, Shteingart S, Farago M, Hadar R, Tirosh B. Direct proteasome binding and subsequent degradation of unspliced XBP-1 prevent its intracellular aggregation. Febs Letters. 584: 67-73. PMID 19941857 DOI: 10.1016/J.Febslet.2009.11.069  0.84
2009 Lavelin I, Beer A, Kam Z, Rotter V, Oren M, Navon A, Geiger B. Discovery of novel proteasome inhibitors using a high-content cell-based screening system. Plos One. 4: e8503. PMID 20041034 DOI: 10.1371/Journal.Pone.0008503  0.84
2009 Navon A, Ciechanover A. The 26 S proteasome: from basic mechanisms to drug targeting. The Journal of Biological Chemistry. 284: 33713-8. PMID 19812037 DOI: 10.1074/Jbc.R109.018481  0.84
2009 Medalia N, Beer A, Zwickl P, Mihalache O, Beck M, Medalia O, Navon A. Architecture and molecular mechanism of PAN, the archaeal proteasome regulatory ATPase. The Journal of Biological Chemistry. 284: 22952-60. PMID 19363223 DOI: 10.1074/Jbc.M809643200  0.84
2008 Kario E, Tirosh B, Ploegh HL, Navon A. N-linked glycosylation does not impair proteasomal degradation but affects class I major histocompatibility complex presentation Journal of Biological Chemistry. 283: 244-254. PMID 17951257 DOI: 10.1074/Jbc.M706237200  0.84
2007 Horwitz AA, Navon A, Groll M, Smith DM, Reis C, Goldberg AL. ATP-induced structural transitions in PAN, the proteasome-regulatory ATPase complex in Archaea. The Journal of Biological Chemistry. 282: 22921-9. PMID 17553803 DOI: 10.1074/Jbc.M702846200  0.84
2006 Besche H, Navon A, Zwickl P. The membrane-bound Lon protease from Thermoplasma displays unfolding activity Israel Journal of Chemistry. 46: 225-229. DOI: 10.1560/0ENV-NQ8B-2WG6-NH8R  0.84
2005 Costanzi J, Sidransky D, Navon A, Goldsweig H. Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnase. Cancer Investigation. 23: 643-50. PMID 16305992 DOI: 10.1080/07357900500283143  0.84
2002 Navon A, Ittah V, Scheraga HA, Haas E. Formation of the hydrophobic core of ribonuclease A through sequential coordinated conformational transitions. Biochemistry. 41: 14225-31. PMID 12450386 DOI: 10.1021/Bi020506P  0.84
2001 Navon A, Goldberg AL. Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome Molecular Cell. 8: 1339-1349. PMID 11779508 DOI: 10.1016/S1097-2765(01)00407-5  0.84
2001 Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proceedings of the National Academy of Sciences of the United States of America. 98: 14440-5. PMID 11717410 DOI: 10.1073/Pnas.251541198  0.84
1998 Schwartz Y, Ben-Dor I, Navon A, Motro B, Nir U. Tyrosine phosphorylation of the TATA element modulatory factor by the FER nuclear tyrosine kinases Febs Letters. 434: 339-345. PMID 9742951 DOI: 10.1016/S0014-5793(98)01003-5  0.84
1996 Planchenault T, Navon A, Schulze AJ, Goldberg ME. Transient non-native interactions in early folding intermediates do not influence the folding kinetics of Escherichia coli tryptophan synthase β2 subunits European Journal of Biochemistry. 240: 615-621. PMID 8856062  0.84
1995 Tokatlidis K, Friguet B, Deville-Bonne D, Baleux F, Fedorov AN, Navon A, Djavadi-Ohaniance L, Goldberg ME. Nascent chains: folding and chaperone interaction during elongation on ribosomes Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 348: 89-95. PMID 7770491  0.84
1995 Navon A, Schulze AJ, Guillou Y, Zylinski CA, Baleux F, Expert-Bezancon N, Friguet B, Djavadi-Ohaniance L, Goldberg ME. Importance of residues 2-9 in the immunoreactivity, subunit interactions, and activity of the β2 subunit of Escherichia coli tryptophan synthase Journal of Biological Chemistry. 270: 4255-4261. PMID 7533160 DOI: 10.1074/jbc.270.9.4255  0.84
1994 Navon A, Schwarz Y, Hazan B, Kassir Y, Nir U. Meiosis-dependent tyrosine phosphorylation of a yeast protein related to the mouse p51ferT Mgg Molecular &Amp; General Genetics. 244: 160-167. PMID 8052235 DOI: 10.1007/BF00283517  0.84
1993 Friguet B, Fedorov A, Serganov AA, Navon A, Goldberg ME. A Radioimmunoassay-Based Method for Measuring the True Affinity of a Monoclonal Antibody with Trace Amounts of Radioactive Antigen: Illustration with the Products of a Cell-Free Protein Synthesis System Analytical Biochemistry. 210: 344-350. PMID 8512069 DOI: 10.1006/abio.1993.1206  0.84
Show low-probability matches.